Jazz Pharmaceuticals plc (JAZZ)
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company offers Xywav to treat cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia (IH); Epidiolex for seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC); Rylaze for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma; Enrylaze to treat acute lymphoblastic leukemia and lymphoblastic lymphoma; Zepzelca for the treatment of metastatic small cell lung cancer with disease progression on or after platinum-based chemotherapy; Ziihera to treat HER2-positive biliary tract cancers; Modeyso for the treatment of diffuse midline glioma harboring an H3 K27M mutation; and Defitelio to treat severe veno-occlusive disease. It also develops Zanidatamab in Phase 3 trial to treat HER2-positive gastroesophageal adenocarcinoma (GEA) and biliary tract cancers (BTC); Dordaviprone to treat H3 K27M-mutant diffuse glioma; and Vyxeos for the treatment of newly-diagnosed therapy-related acute myeloid leukemia. In addition, the company is developing Zanidatamab to treat neoadjuvant and adjuvant breast cancer; Vyxeos for the treatment of High-risk MDS, newly diagnosed untreated patients with high-risk AML, and De novo intermediate or adverse risk AML stratified by genomics; and JZP3507 to treat pheochromocytoma and paraganglioma that are in Phase 2 clinical trials. Further, it develops JZP815 to treat Raf and Ras mutant tumors; JZP898 for the IFN INDUKIN molecule in solid tumors; and JZP047 to treat absence epilepsy that are in Phase 1 clinical trials. The company has licensing and collaboration agreements with Redx Pharma plc, Autifony Therapeutics Limited, Zymeworks Inc., Sumitomo Pharma Co., Ltd., and Werewolf Therapeutics, Inc. Jazz Pharmaceuticals plc was founded in 2003 and is headquartered in Dublin, Ireland.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Jazz Pharmaceuticals plc
NASDAQ:JAZZHealthcare · Biotechnology
+3.92%$215.98
AH$215.98+0.00%vs close
Mkt Cap$14.02B
Float62.17M
O/S64.91M
Vol
$ Vol
RVOL
Inst Own99.9%
SI9.4%
Earnings
Dilution
Financials Summary
Revenue$4.27B
Net Income-$356.15M
Total Assets$11.66B
Free Cash Flow$1.15B
Debt & Equity
Debt 56%
Equity 44%
Total Debt$5.42B
Total Equity$4.32B
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in JAZZ's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$11.66B
Liabilities$7.34B
Accounts Receivable$830.75M
Accounts Payable$122.06M
Inventory$416.96M
PP&E (Net)$258.74M
Goodwill$1.83B
Intangible Assets$4.43B
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | FY 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 | 2005-12-31 | 2004-12-31 |
| Revenue | $4.27B | $4.07B | $3.83B | $3.66B | $3.09B | $2.36B | $2.16B | $1.89B | $1.62B | $1.49B | $1.32B | $1.17B | $872.42M | $585.98M | $272.28M | $173.78M | $128.45M | $67.51M | $65.3M | $44.86M | $21.44M | $0 |
| YoY Growth | 4.9% | 6.1% | 4.8% | 18.3% | 30.9% | 9.3% | 14.3% | 16.8% | 8.8% | 12.3% | 13.0% | 34.4% | 48.9% | 115.2% | 56.7% | 35.3% | 90.3% | 3.4% | 45.6% | 109.2% | - | - |
| Cost of Revenue | $503.3M | $445.71M | $435.58M | $540.52M | $440.76M | $148.92M | $127.93M | $121.54M | $110.19M | $105.39M | $102.53M | $117.42M | $102.15M | $78.42M | $13.94M | $13.56M | $9.64M | $13.92M | $8.9M | $6.97M | $4.29M | $0 |
| Gross Profit | $3.76B | $3.62B | $3.4B | $3.12B | $2.65B | $2.21B | $2.03B | $1.77B | $1.51B | $1.38B | $1.22B | $1.06B | $770.28M | $507.55M | $258.33M | $160.22M | $118.81M | $53.59M | $56.4M | $37.89M | $17.15M | $0 |
| Gross Margin | 88.2% | 89.0% | 88.6% | 85.2% | 85.8% | 93.7% | 94.1% | 93.6% | 93.2% | 92.9% | 92.3% | 90.0% | 88.3% | 86.6% | 94.9% | 92.2% | 92.5% | 79.4% | 86.4% | 84.5% | 80.0% | - |
| Research and Development | $782.74M | $884M | $849.66M | $590.45M | $505.75M | $335.38M | $299.73M | $226.62M | $198.44M | $162.3M | $135.25M | $85.18M | $46.62M | $20.48M | $14.12M | $25.61M | $36.56M | $69.96M | $69.79M | $54.96M | $45.78M | $0 |
| Selling, General, and Administrative | $1.81B | $1.39B | $1.34B | $1.42B | $1.45B | $854.23M | $736.94M | $683.53M | $544.16M | $502.89M | $449.12M | $406.11M | $304.3M | $223.88M | $108.94M | $69M | $58.65M | $111.4M | $78.54M | $51.38M | $23.55M | $0 |
| Other | $947.86M | $637.31M | $627.28M | $1.18B | $525.77M | $646.97M | $464.79M | $244.39M | $237.06M | $125.74M | $129.69M | $368.57M | $84.03M | $65.35M | $7.45M | $7.83M | $7.67M | $42.59M | $46.85M | $9.6M | $26.26M | -$24.8M |
| Total Operating Expenses | $3.54B | $2.91B | $2.82B | $3.18B | $2.48B | $1.84B | $1.5B | $1.15B | $979.66M | $790.93M | $714.06M | $859.87M | $429.96M | $309.71M | $130.5M | $102.43M | $102.88M | $223.96M | $195.18M | $115.94M | $95.59M | -$24.8M |
| Operating Income (EBIT) | $224.42M | $716.63M | $578.58M | -$65.53M | $170.28M | $378.07M | $532.37M | $614.84M | $528.84M | $591.65M | $508.22M | $195.59M | $340.31M | $197.84M | $127.83M | $57.79M | $15.93M | -$170.37M | -$138.78M | -$78.05M | -$78.44M | -$24.8M |
| Operating Margin | 5.3% | 17.6% | 15.1% | -1.8% | 5.5% | 16.0% | 24.6% | 32.5% | 32.7% | 39.8% | 38.4% | 16.7% | 39.0% | 33.8% | 46.9% | 33.3% | 12.4% | -252.3% | -212.5% | -174.0% | -365.8% | - |
| Interest Expense | $195.05M | $238.1M | $289.44M | $288.24M | $278.77M | $99.71M | $72.26M | $78.5M | $77.76M | $61.94M | $56.92M | $52.71M | $26.92M | $16.87M | $1.68M | $12.73M | $22.8M | $19.74M | $0 | $0 | $0 | $0 |
| Interest Income | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $75K | $6K | $34K | $1.83M | $0 | $0 | $0 | $0 |
| Other Income (Expense) | -$853.01M | -$247.94M | -$283.66M | -$317.18M | -$283.83M | -$105.94M | -$82.16M | -$87.58M | -$88.73M | -$59.59M | -$72.29M | -$44.03M | -$32.36M | -$58.59M | -$2.85M | -$25.01M | $0 | $0 | $0 | $0 | $0 | $643K |
| Income Before Tax (EBT) | -$628.59M | $468.69M | $294.92M | -$382.7M | -$113.55M | $272.13M | $450.21M | $527.26M | $440.11M | $532.07M | $435.93M | $151.56M | $307.95M | $177.35M | $124.98M | $32.78M | -$6.84M | -$184.34M | -$138.83M | -$59.39M | -$85.16M | -$24.8M |
| Income Tax Expense | -$272.44M | -$91.43M | -$119.91M | -$158.65M | $216.12M | $33.52M | -$73.15M | $80.16M | -$47.74M | $135.24M | $106.4M | $94.23M | $91.64M | -$83.79M | $0 | $0 | $0 | $0 | $48K | -$18.66M | $28.01M | $24.8M |
| Net Income | -$356.15M | $560.12M | $414.83M | -$224.06M | -$328.95M | $238.62M | $523.37M | $447.1M | $487.85M | $396.83M | $329.54M | $58.39M | $216.31M | $288.59M | $124.98M | $32.78M | -$6.84M | -$184.34M | -$138.83M | -$59.39M | -$85.16M | -$24.8M |
| Net Income Margin | -8.3% | 13.8% | 10.8% | -6.1% | -10.6% | 10.1% | 24.2% | 23.6% | 30.1% | 26.7% | 24.9% | 5.0% | 24.8% | 49.2% | 45.9% | 18.9% | -5.3% | -273.0% | -212.6% | -132.4% | -397.1% | - |
| Supplementary Data | ||||||||||||||||||||||
| EPS | -5.84 | 9.06 | 6.55 | -3.58 | -5.51 | 4.28 | 9.22 | 7.45 | 8.13 | 6.56 | 5.38 | 0.98 | 3.71 | 5.09 | 3.01 | 0.90 | -0.23 | -7.19 | -10.04 | -4.41 | -6.32 | -1.84 |
| Diluted EPS | -5.84 | 8.65 | 6.10 | -3.58 | -5.51 | 4.22 | 9.09 | 7.30 | 7.96 | 6.41 | 5.23 | 0.93 | 3.51 | 4.79 | 2.67 | 0.83 | -0.23 | -7.19 | -10.04 | -4.41 | -6.32 | -1.84 |
| Weighted Average OS | 60.98M | 61.84M | 63.29M | 62.54M | 59.69M | 55.71M | 56.75M | 59.98M | 60.02M | 60.50M | 61.23M | 59.75M | 58.30M | 56.64M | 41.50M | 36.34M | 30.02M | 25.65M | 13.83M | 13.47M | 13.47M | 13.47M |
| EBITDA | $262.76M | $1.52B | $1.45B | $1.47B | $1.03B | $1.04B | $1.01B | $932.66M | $779M | $753.88M | $665.97M | $583.7M | $454.11M | $310.18M | $134.41M | $54.21M | $25.03M | -$125.58M | -$128.25M | -$67.74M | -$51.7M | -$24.8M |
| EBITDA Margin | 6.2% | 37.4% | 37.8% | 40.1% | 33.2% | 44.2% | 46.8% | 49.3% | 48.1% | 50.7% | 50.3% | 49.8% | 52.1% | 52.9% | 49.4% | 31.2% | 19.5% | -186.0% | -196.4% | -151.0% | -241.1% | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 | 2005-12-31 |
| Assets | |||||||||||||||||||||
| Current Assets | |||||||||||||||||||||
| Cash and Cash Equivalents | $1.39B | $2.41B | $1.51B | $881.48M | $591.45M | $1.06B | $637.34M | $309.62M | $386.04M | $365.96M | $988.78M | $684.04M | $636.5M | $387.2M | $82.08M | $44.79M | $15.6M | $24.9M | $102.94M | $78.95M | $20.61M |
| Short-Term Investments | $1.05B | $580M | $120M | $0 | $0 | $1.07B | $440M | $515M | $215M | $60M | $0 | $0 | $0 | $0 | $75.82M | $0 | $0 | $1M | $0 | $0 | $0 |
| Cash and Short-Term Investments | $2.44B | $2.99B | $1.63B | $881.48M | $591.45M | $2.13B | $1.08B | $824.62M | $601.03M | $425.96M | $988.78M | $684.04M | $636.5M | $387.2M | $157.9M | $44.79M | $15.6M | $25.91M | $102.94M | $78.95M | $20.61M |
| Accounts Receivable | $830.75M | $716.76M | $705.79M | $651.49M | $563.36M | $396.49M | $355.99M | $263.84M | $224.13M | $234.24M | $209.69M | $186.37M | $124.81M | $75.48M | $34.37M | $22.08M | $12.31M | $6.64M | $5.39M | $5.38M | $3.6M |
| Inventory | $416.96M | $480.44M | $597.04M | $714.06M | $1.07B | $95.4M | $78.61M | $52.96M | $43.24M | $34.05M | $19.45M | $30.04M | $28.67M | $26.52M | $3.91M | $5.05M | $3.43M | $4.79M | $2.21M | $3.03M | $3.26M |
| Other Current Assets | $323.95M | $261.54M | $320.81M | $267.19M | $252.39M | $152.49M | $78.89M | $67.57M | $76.69M | $29.31M | $19.05M | $102.59M | $67.46M | $54.93M | $1.26M | $679K | $3.97M | $4.79M | $381K | $762K | $671K |
| Total Current Assets | $4.17B | $4.63B | $3.44B | $2.61B | $2.61B | $2.84B | $1.63B | $1.23B | $968.28M | $748.07M | $1.26B | $1.02B | $864.62M | $551.57M | $199.13M | $74.46M | $36.95M | $44M | $116.09M | $91.56M | $31.38M |
| Long-Term Assets | |||||||||||||||||||||
| Property, Plant & Equipment Net | $258.74M | $227M | $234.99M | $301.38M | $343.42M | $257.1M | $270.89M | $200.36M | $170.08M | $107.49M | $85.57M | $58.36M | $14.25M | $7.28M | $1.56M | $690K | $1.12M | $2.51M | $3.94M | $2.11M | $1.94M |
| Goodwill | $1.83B | $1.72B | $1.75B | $1.69B | $1.83B | $958.3M | $920.02M | $927.63M | $947.54M | $893.81M | $657.14M | $702.71M | $450.46M | $442.6M | $38.21M | $38.21M | $38.21M | $38.21M | $38.21M | $38.21M | $38.88M |
| Intangible Assets | $4.43B | $4.76B | $5.42B | $5.79B | $7.15B | $2.2B | $2.44B | $2.73B | $2.98B | $3.01B | $1.19B | $1.44B | $812.4M | $869.95M | $14.59M | $22.03M | $29.86M | $32.53M | $36.04M | $69.14M | $78.74M |
| Long-Term Investments | $4.3M | $4.33M | $0 | $5.5M | $5M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $869.13M | $560.25M | $477.83M | $0 | $0 | $254.92M | $221.4M | $57.88M | $34.56M | $15.06M | $122.86M | $75.49M | $74.6M | $74.85M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $102.28M | $119.64M | $73.94M | $435.14M | $358.94M | $30.96M | $55.34M | $52.28M | $24.09M | $23.8M | $16.48M | $49.1M | $21.91M | $20.24M | $87K | $335K | $1.25M | $246K | $13.27M | $13.55M | $13.83M |
| Total Long-Term Assets | $7.49B | $7.38B | $7.96B | $8.23B | $9.69B | $3.7B | $3.91B | $3.97B | $4.16B | $4.05B | $2.1B | $2.32B | $1.37B | $1.41B | $54.44M | $61.27M | $70.44M | $73.5M | $91.46M | $123.01M | $133.4M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $11.66B | $12.01B | $11.39B | $10.84B | $12.3B | $6.54B | $5.54B | $5.2B | $5.12B | $4.8B | $3.36B | $3.34B | $2.24B | $1.97B | $253.57M | $135.73M | $107.4M | $117.5M | $207.55M | $214.57M | $164.78M |
| Liabilities | |||||||||||||||||||||
| Current Liabilities | |||||||||||||||||||||
| Accounts Payable | $122.06M | $77.87M | $102.75M | $90.76M | $100.3M | $26.95M | $47.55M | $40.6M | $24.37M | $22.41M | $21.81M | $25.13M | $21M | $15.89M | $5.13M | $3.05M | $2.16M | $5.74M | $2.86M | $5.44M | $4.79M |
| Short-Term Debt | $1.03B | $31M | $604.95M | $31M | $31M | $246.32M | $33.39M | $33.39M | $40.6M | $36.09M | $37.59M | $9.43M | $5.57M | $29.69M | $0 | $23.41M | $33.16M | $122.41M | $3.46M | $2.19M | $0 |
| Current Income Tax Payable | $56.39M | $18.76M | $35.07M | $7.72M | $9.61M | $25.2M | $10.96M | $1.2M | $21.58M | $4.51M | $1.81M | $7.59M | $336K | $39.88M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $463K | $2.09M | $2.55M | $4.72M | $5.41M | $8.62M | $1.12M | $1.37M | $1.14M | $1.14M | $1.14M | $1.14M | $1.27M | $2.67M | $12.32M | $1.49M | $1.42M | $0 |
| Other Current Liabilities | $245.99M | $189.76M | $142.32M | $169.41M | $193.1M | $124.59M | $85.03M | $62.51M | $63.99M | $47.73M | $41.7M | $69.61M | $109.2M | $51.56M | $27.77M | $4.13M | $2.95M | $16.53M | $0 | $8.52M | $7.43M |
| Total Current Liabilities | $2.24B | $1.04B | $1.54B | $933.19M | $809.3M | $653.75M | $364.49M | $345.49M | $293.95M | $257.41M | $226.64M | $216.8M | $204.03M | $191.54M | $52.87M | $59.94M | $59.24M | $173.49M | $36.86M | $30.52M | $23.34M |
| Long-Term Liabilities | |||||||||||||||||||||
| Long-Term Debt | $4.33B | $6.08B | $5.11B | $5.69B | $6.02B | $1.85B | $1.57B | $1.56B | $1.54B | $1.99B | $1.15B | $1.33B | $544.4M | $427.07M | $0 | $24.63M | $91.11M | $0 | $75.12M | $74.28M | $73.63M |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $463K | $2.31M | $4.86M | $9.58M | $16.11M | $2.6M | $3.72M | $4.5M | $5.72M | $6.78M | $7.92M | $9.13M | $10.22M | $11.33M | $12.47M | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $594.47M | $676.74M | $847.71M | $944.34M | $1.3B | $130.4M | $224.09M | $309.1M | $383.47M | $556.73M | $294.49M | $375.05M | $168.5M | $178.39M | $0 | $0 | $0 | $0 | -$12.47M | $0 | $0 |
| Other Long-Term Liabilities | $124.52M | $86.61M | $104.75M | $106.81M | $117M | $101.15M | $109.37M | $218.88M | $176.61M | $112.62M | $69.25M | $38.39M | $20.04M | $41.42M | $0 | $11.48M | $19.69M | $25.55M | $28.12M | $286.06M | $186.06M |
| Total Long-Term Liabilities | $5.1B | $6.88B | $6.12B | $6.82B | $7.52B | $2.22B | $2.06B | $2.1B | $2.12B | $2.67B | $1.53B | $1.75B | $738.66M | $653.66M | $7.92M | $45.24M | $120.98M | $36.88M | $115.71M | $360.35M | $259.69M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $7.34B | $7.92B | $7.66B | $7.75B | $8.33B | $2.88B | $2.43B | $2.45B | $2.41B | $2.92B | $1.76B | $1.97B | $942.69M | $845.2M | $60.78M | $105.18M | $180.23M | $210.38M | $152.56M | $390.87M | $283.03M |
| Stockholders' Equity | |||||||||||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $6K | $61K | $61K | $61K | $61K | $61K | $61K | $61K | $61K | $61K | $61K | $61K | $61K | $61K | $4K | $4K | $3K | $3K | $2K | $0 | $0 |
| Retained Earnings | $646.18M | $1.13B | $878.66M | $733.59M | $830.23M | $1.16B | $1.07B | $841.05M | $917.96M | $528.91M | $302.69M | $34.7M | $18.53M | -$61.3M | -$349.88M | -$474.87M | -$507.64M | -$500.81M | -$316.47M | -$177.64M | -$118.25M |
| Comprehensive Income & Other | -$568.6M | -$947.67M | -$842.15M | -$1.13B | -$400.36M | -$134.35M | -$223.39M | -$197.79M | -$140.88M | -$317.33M | -$267.47M | -$122.1M | $56.15M | $31.05M | -$31K | $0 | $0 | $4K | $19K | $12K | $4K |
| Other Stockholders' Equity | $3.67B | $2.97B | $2.86B | $2.35B | $3.13B | $2.5B | $2.04B | $1.92B | $1.8B | $1.35B | $1.3B | $1.34B | $1.28B | $1.18B | $542.67M | $505.41M | $434.81M | $407.93M | $371.46M | $1.35M | $4K |
| Total Equity | $4.32B | $4.09B | $3.74B | $3.09B | $3.97B | $3.66B | $3.11B | $2.76B | $2.71B | $1.88B | $1.6B | $1.37B | $1.3B | $1.12B | $192.79M | $30.55M | -$72.83M | -$92.88M | $54.99M | -$176.3M | -$118.25M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $64K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $11.66B | $12.01B | $11.39B | $10.84B | $12.3B | $6.54B | $5.54B | $5.2B | $5.12B | $4.8B | $3.36B | $3.34B | $2.24B | $1.97B | $253.57M | $135.73M | $107.4M | $117.5M | $207.55M | $214.57M | $164.78M |
| Supplementary Data | |||||||||||||||||||||
| Total Debt | $5.42B | $6.16B | $5.79B | $5.81B | $6.15B | $2.25B | $1.77B | $1.6B | $1.58B | $2.03B | $1.19B | $1.34B | $549.98M | $456.76M | $0 | $48.04M | $124.27M | $122.41M | $78.58M | $76.47M | $73.63M |
| Net Debt | $4.03B | $3.75B | $4.29B | $4.93B | $5.56B | $1.19B | $1.13B | $1.29B | $1.2B | $1.66B | $199.66M | $658.39M | -$86.53M | $69.56M | -$82.08M | $3.25M | $108.67M | $97.51M | -$24.37M | -$2.47M | $53.02M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 | 2005-12-31 |
| Operating Activities | |||||||||||||||||||||
| Net Income | -$356.15M | $560.12M | $414.83M | -$224.06M | -$329.67M | $238.62M | $523.37M | $447.1M | $487.85M | $396.83M | $329.53M | $57.33M | $216.31M | $288.59M | $124.98M | $32.78M | -$6.84M | -$184.34M | -$138.83M | -$59.39M | -$85.16M |
| Depreciation & Amortization | $696.3M | $660.07M | $638.7M | $629.47M | $552.48M | $278.25M | $370.16M | $216.73M | $165.15M | $113.78M | $108.06M | $133.68M | $82.09M | $74.23M | $7.83M | $8.71M | $9.1M | $15.03M | $10.53M | $10.31M | $5.44M |
| Deferred Income Tax | -$444.97M | -$208.33M | -$260.22M | -$292.25M | $69.2M | -$136.94M | -$236.61M | -$88.81M | -$225.59M | -$41.16M | -$61.21M | -$43.42M | -$10.1M | -$113.86M | -$123.7M | $12.57M | $0 | $26.81M | -$11.91M | $0 | $0 |
| Stock-Based Compensation | $291.13M | $248.04M | $226.84M | $222M | $189.01M | $121M | $110.56M | $102.44M | $106.9M | $98.77M | $91.55M | $69.64M | $44.55M | $23.01M | $20.7M | $8.22M | $5.96M | $8.11M | $6.06M | $0 | $0 |
| Changes in Working Capital: | |||||||||||||||||||||
| Accounts Receivable | -$106.28M | -$21.11M | -$51.88M | -$90.14M | -$92.73M | -$38.65M | -$92.33M | -$40.13M | $12.28M | -$25.6M | -$24.84M | -$55.04M | -$48.85M | -$4.72M | -$12.29M | -$9.77M | -$5.67M | -$1.25M | -$250K | $0 | $0 |
| Inventory | -$86.04M | -$45.54M | -$13.42M | -$49.64M | -$48.86M | -$30.54M | -$32.79M | -$18.51M | -$8.67M | -$17.02M | $6.27M | -$7.63M | -$8.52M | $1.7M | $1.3M | -$1.64M | $883K | -$2.63M | $459K | -$521K | -$219K |
| Accounts Payable | $39.85M | -$20.07M | $9.6M | -$11.22M | $57.02M | -$18.93M | $4.77M | $17.04M | $214K | $361K | -$2.28M | -$37.97M | $5.09M | -$7.29M | $2.08M | $891K | -$3.58M | $2.88M | -$2.59M | $0 | $0 |
| Other Working Capital | $171.37M | $10.01M | -$148.74M | $160.91M | $36.62M | $2.68M | -$29.74M | $64.89M | $22.94M | $19.55M | $14.74M | $49.2M | -$28.68M | $5.16M | $5.32M | $4.71M | -$15.74M | $3.11M | $29.88M | $15.92M | $3.07M |
| Total Working Capital Change | $18.9M | -$76.72M | -$204.44M | $9.9M | -$47.95M | -$85.44M | -$150.08M | $23.29M | $26.77M | -$22.72M | -$6.11M | -$51.44M | -$80.96M | -$5.16M | -$3.59M | -$5.81M | -$24.11M | $2.1M | $27.5M | $15.4M | $2.85M |
| Other Non-Cash Items | $1.15B | $212.72M | $276.29M | $926.92M | $345.44M | $484.15M | $159.01M | $98.16M | $132.01M | $45.04M | $70.12M | $239.98M | $31.72M | -$17.05M | $125.38M | $2.41M | $14K | $2.06M | $25.56M | -$23.67M | $24.71M |
| Net Cash from Operating | $1.36B | $1.4B | $1.09B | $1.27B | $778.51M | $899.65M | $776.4M | $798.9M | $693.09M | $590.54M | $531.94M | $405.76M | $283.62M | $249.75M | $151.6M | $58.87M | -$15.88M | -$130.23M | -$81.09M | -$57.35M | -$52.16M |
| Investing Activities | |||||||||||||||||||||
| Capital Expenditures | -$58.75M | -$38.07M | -$23.96M | -$498.19M | -$27.64M | -$379.25M | -$182.34M | -$131.47M | -$113.95M | -$181.58M | -$35.96M | -$238.97M | -$11.28M | -$22.48M | -$5.78M | -$4.73M | -$6.05M | -$28.74M | -$3.15M | -$1.68M | -$1.41M |
| Acquisitions | -$858.05M | $0 | $0 | $53M | -$6.23B | -$364.25M | -$142.2M | $111.1M | $85M | -$1.5B | $33.7M | -$828.68M | $0 | -$448.61M | -$4.5M | $0 | $0 | $0 | $10.15M | $150K | -$146.12M |
| Purchases of Investments | -$1.83B | -$1.31B | -$390.1M | -$61.04M | -$26.82M | -$2.4B | -$917.1M | -$1.17B | -$385M | -$65.28M | $0 | $0 | $0 | -$37.44M | -$79.89M | $0 | $0 | $0 | -$10.85M | -$1.71M | $0 |
| Sales of Investments | $1.36B | $845M | $270M | $60M | $1.09B | $1.75B | $985M | $855M | $230M | $173.75M | $0 | $0 | $0 | $113.23M | $4.03M | $2.59M | $1M | $3.44M | $10.85M | $1.71M | $5.95M |
| Other Investing Activities | -$122.83M | -$10M | -$19M | $0 | -$17.89M | $378.51M | $101.33M | -$63.2M | -$85M | -$173.75M | $33.7M | -$202.63M | -$6.29M | -$389.32M | $4.9M | -$1.41M | -$1.07M | $13.36M | -$1.66M | $25K | -$12.18M |
| Net Cash from Investing | -$1.51B | -$508.19M | -$163.06M | -$446.23M | -$5.21B | -$1.01B | -$155.3M | -$394.49M | -$268.95M | -$1.75B | -$2.25M | -$1.07B | -$11.28M | -$395.29M | -$81.23M | -$2.14M | -$6.12M | -$11.94M | $5.34M | -$1.51M | -$153.75M |
| Financing Activities | |||||||||||||||||||||
| Debt Repaid | $781M | -$374.77M | $31M | $582.01M | -$3.87B | -$591.81M | $33.39M | $25.72M | $326.7M | -$966.34M | $167.12M | -$1.18B | -$87.52M | -$439.04M | $42.15M | $87.89M | - | $504K | - | - | - |
| Common Stock Issuance | $107.86M | $20.65M | $46.46M | $0 | $135.26M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $56.82M | $6.78M | $24.51M | $98.48M | $100M | $177.85M |
| Common Stock Repurchases | -$125.02M | -$311.43M | -$269.76M | -$54K | $0 | -$146.54M | -$301.45M | -$523.67M | -$98.8M | -$278.3M | -$61.55M | -$42.22M | -$136.48M | -$25.3M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$75.22M | -$63.47M | -$50.95M | -$45.44M | -$35.6M | $99.68M | -$16.74M | -$23.08M | $16.39M | $24.17M | -$26.18M | -$111.74M | $30.53M | $9.49M | $0 | $5.59M | $5.91M | $1.17M | $0 | $15M | $15M |
| Net Cash from Financing | -$873.38M | $20.52M | -$305.25M | -$529.49M | $3.97B | $528.07M | -$293.75M | -$479.13M | -$409.11M | $540.99M | -$214.32M | $712.88M | -$24.03M | $448.53M | -$33.08M | -$27.53M | $12.69M | $64.13M | $99.75M | $117.19M | $192.85M |
| Forex Effect | $6.55M | -$1.68M | $1.14M | -$6.22M | -$3.21M | $374K | $366K | -$1.7M | $5.05M | -$5.04M | -$10.62M | -$3.45M | $997K | $2.13M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$1.02B | $906.55M | $624.83M | $290.03M | -$466.32M | $420.43M | $327.72M | -$76.41M | $20.07M | -$622.82M | $304.74M | $47.54M | $249.31M | $305.12M | $37.28M | $29.2M | -$9.31M | -$78.04M | $24M | $58.33M | -$13.06M |
| Supplementary Data | |||||||||||||||||||||
| Operating Cash Flow | $1.36B | $1.4B | $1.09B | $1.27B | $778.51M | $899.65M | $776.4M | $798.9M | $693.09M | $590.54M | $531.94M | $405.76M | $283.62M | $249.75M | $151.6M | $58.87M | -$15.88M | -$130.23M | -$81.09M | -$57.35M | -$52.16M |
| Capital Expenditure | -$209.75M | -$48.07M | -$23.96M | -$498.19M | -$45.53M | -$379.25M | -$182.34M | -$131.47M | -$113.95M | -$181.58M | -$35.96M | -$238.97M | -$11.28M | -$22.48M | -$5.78M | -$4.73M | -$6.05M | -$28.74M | -$3.15M | -$1.68M | -$1.41M |
| Free Cash Flow | $1.15B | $1.35B | $1.07B | $773.78M | $732.98M | $520.39M | $594.07M | $667.43M | $579.14M | $408.95M | $495.99M | $166.79M | $272.34M | $227.28M | $145.82M | $54.14M | -$21.93M | -$158.97M | -$84.24M | -$59.03M | -$53.58M |
| Cash at Beginning | $2.41B | $1.51B | $881.48M | $591.45M | $1.06B | $637.34M | $309.62M | $386.04M | $365.96M | $988.78M | $684.04M | $636.5M | $387.2M | $82.08M | $44.79M | $15.6M | $24.9M | $102.94M | $78.95M | $20.61M | $33.68M |
| Cash at End | $1.39B | $2.41B | $1.51B | $881.48M | $591.45M | $1.06B | $637.34M | $309.62M | $386.04M | $365.96M | $988.78M | $684.04M | $636.5M | $387.2M | $82.08M | $44.79M | $15.6M | $24.9M | $102.94M | $78.95M | $20.61M |